Bladder Cancer
Efficacy of Cretostimogene Grenadenorepvec and Pembrolizumab in BCG-Resistant NMIBC - Expert Commentary
July 19, 2024
The current role of pentafecta in the reporting of radical cystectomy outcomes: a scoping review.
July 19, 2024
Bladder Cancer Advocacy Network (BCAN) Announces $600,000 in Funding to Propel Breakthroughs in Bladder Cancer Research
July 16, 2024
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer.
July 16, 2024
PARP Inhibitors for Metastatic Urothelial Carcinoma: A Systematic Review of Efficacy and Safety.
July 15, 2024